Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Obes Rev. 2021 Oct;22(10):e13280. doi: 10.1111/obr.13280. Epub 2021 May 24.
Weight gain prevention is a global public health priority to address escalating adiposity in adults. This review evaluates the efficacy of weight gain prevention trials targeting adults aged 18-50 years and adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol. Trials of any duration from inception to May 2020 that evaluated a weight gain prevention intervention (using either prescriptive diet, prescriptive physical activity, prescriptive diet, and/or physical activity or non-prescriptive lifestyle) and included weight or body mass index (weight [kg]/height [m ]) were eligible. Twenty-nine trials across 34 publications (participants n = 37,407) were included. Intervention resulted in less weight gain compared with controls (-1.15 kg [95% CI -1.50, -0.80 kg] p < 0.001). Subgroup analysis demonstrated greater effectiveness with prescriptive (-1.60 kg [95% CI -2.00, -1.19] p < 0.001) compared with non-prescriptive (-0.81 kg [95% CI 1.10, -0.53] p < 0.001) intervention types. Interventions had greatest impact in healthy weight (18.5-24.9 kg/m ) (-0.82 kg [95% CI -1.5, -0.50] p < 0.001) or overweight (25.0-29.9 kg/m ) (-1.48 kg [95% CI -1.85, -1.12] p < 0.001) compared with obese populations (≥30.0 kg/m ) (-0.56 kg [95% CI -1.40, 0.27] p = 0.19). These findings demonstrate that lifestyle intervention prevents cumulative weight gain in non-obese adults, with future research required to inform cost-effectiveness and implementation feasibility.
体重增加预防是解决成年人肥胖问题的全球公共卫生重点。本综述评估了针对 18-50 岁成年人的体重增加预防试验的疗效,并遵循系统评价和荟萃分析的首选报告项目(PRISMA)协议。从开始到 2020 年 5 月的任何持续时间的试验,评估了体重增加预防干预措施(使用规定饮食、规定体力活动、规定饮食和/或体力活动或非规定生活方式),并包括体重或体重指数(体重[kg]/身高[m])是合格的。共有 34 篇文献中的 29 项试验(参与者 n=37407)入选。与对照组相比,干预组体重增加较少(-1.15kg[95%CI-1.50,-0.80kg],p<0.001)。亚组分析表明,规定干预措施(-1.60kg[95%CI-2.00,-1.19],p<0.001)比非规定干预措施(-0.81kg[95%CI1.10,-0.53],p<0.001)更有效。在健康体重(18.5-24.9kg/m)(-0.82kg[95%CI-1.5,-0.50],p<0.001)或超重(25.0-29.9kg/m)(-1.48kg[95%CI-1.85,-1.12],p<0.001)人群中,干预措施的影响最大,而在肥胖人群(≥30.0kg/m)中(-0.56kg[95%CI-1.40,0.27],p=0.19),影响较小。这些发现表明,生活方式干预可预防非肥胖成年人的体重累积增加,需要进一步研究以确定成本效益和实施可行性。